LivaNova, PLC Announces the First U.S. Implants of Perceval, the Only Sutureless Valve for Aortic Valve Replacement Surgery
March 08, 2016 09:00 ET
|
LivaNova PLC
LONDON, March 08, 2016 (GLOBE NEWSWIRE) -- LivaNova, PLC (NASDAQ:LIVN) (LSE:LIVN) (the “Company”), a global medical technology company and a leader in the treatment of cardiovascular diseases,...
LivaNova, PLC Announces Appointment of Vice President Investor Relations and Corporate Communications
March 03, 2016 09:00 ET
|
LivaNova PLC
LONDON, March 03, 2016 (GLOBE NEWSWIRE) -- LivaNova, PLC (NASDAQ:LIVN) (LSE:LIVN), a global medical technology company and a leader in the treatment of cardiovascular diseases, today announced...
LivaNova PLC Receives Regulatory Approval in Japan for the Solo Smart Stentless Tissue Aortic Valve
February 29, 2016 09:00 ET
|
LivaNova PLC
LONDON, Feb. 29, 2016 (GLOBE NEWSWIRE) -- LivaNova, PLC (NASDAQ:LIVN) (LSE:LIVN), a global medical technology company and a leader in the treatment of cardiovascular diseases, today announced...
LivaNova PLC to Participate in Upcoming Investor Conferences
February 25, 2016 09:00 ET
|
LivaNova PLC
LONDON, Feb. 25, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ:LIVN) (LSE:LIVN) (“LivaNova” or “the Company”), today announced that the Company will participate in the following conferences: ...
LivaNova Reports 2015 Annual and Fourth Quarter Financial Results
February 24, 2016 07:00 ET
|
LivaNova PLC
LONDON, Feb. 24, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ:LIVN) (LSE:LIVN) (“LivaNova” or the “Company”), a global medical technology company, today announced 2015 financial results (see...
LivaNova PLC to Provide Business & Financial Update and Host Webcast and Conference Call on February 24, 2016
February 10, 2016 08:00 ET
|
LivaNova PLC
LONDON, Feb. 10, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ:LIVN); (LSE:LIVN) (“LivaNova” or “the Company”), today announced that the Company will report sales results for the period ended...
LivaNova PLC Announces FDA Approval of Stented Heart Valve CROWN PRT™ for Aortic Valve Disease
February 01, 2016 08:00 ET
|
LivaNova PLC
LONDON, Feb. 01, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ:LIVN) (LSE:LIVN) (the “Company”), a global medical technology company and a leader in the treatment of cardiovascular diseases, today...
LivaNova Receives Regulatory Approval in Japan for KORA 250
January 28, 2016 08:00 ET
|
LivaNova PLC
WORLD’S SMALLEST FULL BODY MRI CONDITIONAL PACING SYSTEMWITH ITS UNIQUE COMBINATION OF SMALL SIZE, EXTENDED LONGEVITY, AND PROPRIETARY TECHNOLOGIES DESIGNED TO IMPROVE PATIENT OUTCOMES, KORA 250...
LivaNova PLC Announces Management Change
January 13, 2016 19:00 ET
|
LivaNova PLC
LONDON, Jan. 13, 2016 (GLOBE NEWSWIRE) -- LivaNova, PLC (NASDAQ:LIVN) (LSE:LIVN) (the “Company”), today announced a change to the leadership of the Neuromodulation Business Unit. Effective...
LivaNova PLC Announces Approval of Perceval
January 11, 2016 09:00 ET
|
LivaNova PLC
LONDON, Jan. 11, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ:LIVN) (LSE:LIVN) (the “Company”) announced that, on January 8, 2016, the Company received approval from the United States Food and...